A new scale to measure severity and change in persons with compulsive
buying is described. Data were gathered during an open-label study in
which compulsive buyers were treated with fluvoxamine, a serotonin reu
ptake inhibitor. The instrument showed good-to-excellent interrater re
liability and high internal consistency. Its 10 separate items showed
at least moderate correlations with the total score. The instrument wa
s also sensitive to clinical change and correlated highly with other m
easures of illness severity. We conclude that this new instrument is b
oth reliable and valid in measuring severity and change in persons wit
h compulsive buying.